Rupert Vessey, Bristol Myers Squibb's President of Research and Early Development

Pro­tein degra­da­tion field turns red hot as Bris­tol My­ers signs up for an­oth­er multi­bil­lion-dol­lar pact

A new sea­son of pro­tein degra­da­tion deals is up­on us.

Just days af­ter Ru­pert Vessey an­ted up on a $1.55 bil­lion deal to ad­vance new …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.